Company Description
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide.
It operates in Commercial Pharmaceuticals and Manufacturing segments.
The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor.
In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers.
The company was founded in 1850 and is headquartered in Durban, South Africa.

Country | ZA |
IPO Date | Apr 5, 2010 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 8,867 |
CEO | Stephen Bradley Saad BCom, CA(SA) |
Contact Details
Address: Aspen Place Durban, ZA | |
Website | https://www.aspenpharma.com |
Stock Details
Ticker Symbol | APNHY |
Exchange | PNK |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | n/a |
CUSIP Number | 04530Y106 |
ISIN Number | US04530Y1064 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Samer Kassem | Chief Executive Officer of Aspen Global Incorporated |
Stephen Bradley Saad BCom, CA(SA) | Group Chief Executive Officer & Executive Director |
Trevor Julian Ziman | Regional Chief Executive Officer of Asia Pacific |
Sean M. Capazorio | Group Chief Financial Officer & Executive Director |
Lorraine Hill | Group Chief Operations Officer |
Michael Guy Attridge B.Com., CA(SA) | Group Chief Advisor |
Raeesa Khan | Group Company Secretary & Chief of Staff |
Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corporate Officer & Executive Director |
Sibongakonke Nkosi | Investor Relations Manager |
Zizipho Mmango | Group Chief Strategic Development Officer |